Brian To

Brian To is the Executive Director of Purification Development at Gilead Sciences, where they lead initiatives in biologics process development. With extensive experience in clinical manufacturing, process validation, and facility start-ups, Brian previously held significant roles at Bayer HealthCare, Boehringer Ingelheim, Resilience, and Merck. They have earned a Ph.D. in Chemical Engineering and an MS in Food Science from the University of Delaware and the University of Wisconsin-Madison, where they also completed a BS in Chemical Engineering.